
The collaboration combines Novo's leadership in diabetes care medicines and GLP-1 therapies with Abbott's extensive healthcare and commercial footprint across the region Abbott will promote and distribute Plosbrio® (semaglutide) across a number of Asia Pacific countries, helping expand...
Pr Newswire Apac
Original source
